BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 12533969)

  • 1. Expression of Ki-67 and PCNA as proliferating markers in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():262-9. PubMed ID: 12533969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 immunohistochemical detection in prostate cancer.
    Sulik M; Guzińska-Ustymowicz K
    Rocz Akad Med Bialymst; 2002; 47():254-61. PubMed ID: 12533968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R; Ayhan A; Ekici S; Ergen A; Ozen H
    BJU Int; 2005 Mar; 95(4):650-4. PubMed ID: 15705097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression.
    Veltri RW; Partin AW; Epstein JE; Marley GM; Miller CM; Singer DS; Patton KP; Criley SR; Coffey DS
    J Cell Biochem Suppl; 1994; 19():249-58. PubMed ID: 7529856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of proliferating cell nuclear antigen immunostaining in lymph node metastases and primary prostate adenocarcinoma after neoadjuvant androgen deprivation therapy.
    Minardi D; Galosi AB; Giannulis I; Montironi R; Polito M; Muzzonigro G
    Scand J Urol Nephrol; 2004; 38(1):19-25. PubMed ID: 15204422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
    Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
    Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
    Revelos K; Petraki C; Gregorakis A; Scorilas A; Papanastasiou P; Tenta R; Koutsilieris M
    In Vivo; 2005; 19(5):911-20. PubMed ID: 16097446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers.
    Czyzewska J; Guzińska-Ustymowicz K; Lebelt A; Zalewski B; Kemona A
    Rocz Akad Med Bialymst; 2004; 49 Suppl 1():64-6. PubMed ID: 15638377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.
    Freedland SJ; deGregorio F; Sacoolidge JC; Elshimali YI; Csathy GS; Dorey F; Reiter RE; Aronson WJ
    J Urol; 2003 Apr; 169(4):1325-30. PubMed ID: 12629353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of proliferating cell nuclear antigen and Ki-67 in malignant ovarian germ cell tumors.
    Liu FS; Chen JT; Liu SC; Shih A; Shih RT; Ho ES
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):695-702. PubMed ID: 10533299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Bcl-2, P53, Ki-67, and caveolin-1 immunostaining in the prediction of biochemical failure after radical prostatectomy in a Japanese population.
    Goto T; Nguyen BP; Nakano M; Ehara H; Yamamoto N; Deguchi T
    Urology; 2008 Jul; 72(1):167-71. PubMed ID: 18384856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.
    Aaltomaa S; Kärjä V; Lipponen P; Isotalo T; Kankkunen JP; Talja M; Mokka R
    Anticancer Res; 2006; 26(6C):4873-8. PubMed ID: 17214354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PCNA and Ki-67 expression in locally confined renal adenocarcinoma. Relationship with various histopathologic variables and prognostic significance].
    Tejido Sánchez A; Sánchez Chapado M; Rosino Sánchez A; Passas Martínez J; Bethencourt Codes F; Ruiz Ramos P; Leiva Galvis O
    Arch Esp Urol; 2002 Apr; 55(3):257-65. PubMed ID: 12068757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens.
    Poulos CK; Daggy JK; Cheng L
    Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
    Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
    Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
    Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC
    Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients.
    Myoung H; Kim MJ; Lee JH; Ok YJ; Paeng JY; Yun PY
    Int J Oral Maxillofac Surg; 2006 Nov; 35(11):1005-10. PubMed ID: 17018251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic factors of prostate cancer: usefulness of Ki-67 expression in preoperative biopsies].
    Ojea Calvo A; Mosteiro Cerviño MJ; Domínguez Freire F; Alonso Rodrigo A; Rodríguez Iglesias B; Benavente Delgado J; Barros Rodríguez JM; González Piñeiro A
    Arch Esp Urol; 2004 Oct; 57(8):805-16. PubMed ID: 15560269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.